Global Rare Disease Testing

Global Rare Disease Testing Market Research Report: Forecast (2021-2026)

By Type (Cardiovascular, Ophthalmological, Neurological, Oncological, Hematological, Endocrine and Metabolism, Gastroenterologist), By Acquisition (Genetic, Externally Acquired), By Technology (Next G Read more

  • Healthcare
  • Sep 2021
  • 234
  • HC44017

A rare disease is any disease that affects less than 5 in 10000 people, states WHO (World Health Organization), There are over 7000 such diseases and most of them have no effective treatment.

According to MarkNtel Advisors, the Global Rare Disease Testing Market is anticipated to grow at a CAGR of around 9.29% during the forecast period, i.e., 2021-26. The market growth primarily attributes to the increasing prevalence of genetic disorders & various types of cancer. In addition to this, the paradigm shifts from reaction to prevention on a global level, increasing research funding, and surging usage of new techniques & developments are other crucial factors driving the market.

The research report “Global Rare Disease Testing Market Analysis, 2021” also states that the global market is expected to grow significantly due to various opportunities that lie within its domain. These include the massive scope toward adopting NGS (Next-Generation Sequencing) in emerging nations and technological advancements in molecular techniques for the whole genome & exome sequencing.

Report Coverage Details
Study Period Historical Data: 2016-19
Base Year: 2020
Forecast Period: 2021-26
CAGR 9.29%
Regions Covered North America: USA, Canada, Mexico
Europe: Germany, UK, France, Italy, Spain
Asia-Pacific:  China, India, Japan, Australia, Singapore
South America: Brazil, and Argentina
Middle East & Africa:  Israel, GCC
Key Companies Profiled Quest Diagnostics Inc., Centogene N.V., Invitae Corporation., 3billion, Inc., Arup Laboratories., Eurofins Scientific., Strand Life Sciences., Ambry Genetics., Color Genomics, Inc., Health Network Laboratories, PreventionGenetics, Progenity, Inc., Myriad Genetics, Inc., Laboratory Corporation of America Holdings, OPKO Health, Inc
Unit Denominations USD Million/Billion

 

The Impact of COVID-19 on Global Rare Disease Testing Market

  • Last year, the COVID-19 pandemic negatively impacted the Global Rare Disease Testing Market.
  • The burgeoning number of COVID-19 cases prioritized healthcare services for COVID-19 patients.
  • It led to worsening situations for patients with rare diseases due to the cancellation of their appointments.
  • Hence, the interrupting care and lack of healthcare services resulted in the underdiagnoses of rare diseases, which, in turn, negatively influenced the market growth globally.
  • Further, rare disease organizations experienced various other challenges, including canceled fundraising events, reduced investments, and the emergence of remote working.
  • However, as the lockdown restrictions got relaxed in later 2020, the market is recovering.
  • Moreover, owing to the resumption of consultation & diagnosis of rare diseases, the market is expected to witness steady growth in the coming years.

  1. Introduction
    1. Definition
    2. Research Process
    3. Glossary
    4. Market Segmentation
  2. Executive Summary
  3. Global Impact of COVID-19 Pandemic on Patients Rare Disease Testing
  4. Global Rare Disease Testing Market Policies, Regulations and Services.
  5. Global Rare Disease Testing Market Dynamics
    1. Growth Drivers
    2. Challenges
    3. Impact Analysis
  6. Global Rare Disease Testing Market Trends & Insights
  7. Global Rare Disease Testing Market Key Strategic Imperatives for Success & Growth
  8. Global Rare Disease Testing Market Analysis, 2016-2026F
    1. Market Size & Analysis
      1. By Revenue
    2. Market Share & Analysis
      1. By Type
        1. Cardiovascular
        2. Ophthalmological
        3. Neurological
        4. Oncological
        5. Hematological
        6. Endocrine and Metabolism
        7. Gastroenterologist
        8. Others
      2. By Acquisition
        1. Genetic
        2. Externally Acquired
      3. By Technology
        1. Next Generation Sequencing
        2. Complete Genome
        3. Complete Exome
        4. Micro Arrays
        5. Others
      4. By Age Group
        1. 0-15 yrs.
        2. 16-30 yrs.
        3. 31-45 yrs.
        4. Others
      5. By Products
        1. Kits & Assays
        2. Panels
        3. Others
      6. By End User
        1. Hospitals
        2. Diagnostics Laboratories
        3. Clinical Laboratories
        4. Contract Research Organizations
        5. Others
      7. By Region
        1. North America
        2. South America
        3. Europe
        4. Middle East & Africa
        5. Asia Pacific
  9. North America Rare Disease Testing Market Analysis, 2016-2026
    1. Market size & Analysis
      1. Market Revenue
    2. Market Share & Analysis
      1. By Type
      2. By Acquisition
      3. By Technology
      4. By Age Group
      5. By Products
      6. By Country
        1. The USA
        2. Canada
        3. Mexico
    3. The US Rare Disease Testing Market Analysis, 2016-2026
      1. Market size & Analysis
        1. Market Revenue
      2. Market Share & Analysis
        1. By Type
        2. By Acquisition
        3. By Technology
        4. By Age Group
        5. By Products
    4. Canada Rare Disease Testing Market Analysis, 2016-2026
      1. Market size & Analysis
        1. Market Revenue
      2. Market Share & Analysis
        1. By Type
        2. By Acquisition
        3. By Technology
        4. By Age Group
        5. By Products
    5. Mexico Rare Disease Testing Market Analysis, 2016-2026
      1. Market size & Analysis
        1. Market Revenue
      2. Market Share & Analysis
        1. By Type
        2. By Acquisition
        3. By Technology
        4. By Age Group
        5. By Products
  10. Latin America Rare Disease Testing Market Analysis, 2016-2026
    1. Market size & Analysis
      1. Market Revenue
    2. Market Share & Analysis
      1. By Type
      2. By Acquisition
      3. By Technology
      4. By Age Group
      5. By Products
      6. By Country
        1. Brazil
        2. Argentina
        3. Others
    3. Brazil Rare Disease Testing Market Analysis, 2016-2026
      1. Market size & Analysis
        1. Market Revenue
      2. Market Share & Analysis
        1. By Type
        2. By Acquisition
        3. By Technology
        4. By Age Group
        5. By Products
    4. Argentina Rare Disease Testing Market Analysis, 2016-2026
      1. Market size & Analysis
        1. Market Revenue
      2. Market Share & Analysis
        1. By Type
        2. By Acquisition
        3. By Technology
        4. By Age Group
        5. By Products
  11. Europe Rare Disease Testing Market Analysis, 2016-2026
    1. Market size & Analysis
      1. Market Revenue
    2. Market Share & Analysis
      1. By Type
      2. By Acquisition
      3. By Technology
      4. By Age Group
      5. By Products
      6. By Country
        1. Germany
        2. Italy
        3. France
        4. Spain
        5. UK
    3. Germany Rare Disease Testing Market Analysis, 2016-2026
      1. Market size & Analysis
        1. Market Revenue
      2. Market Share & Analysis
        1. By Type
        2. By Acquisition
        3. By Technology
        4. By Age Group
        5. By Products
    4. Italy Rare Disease Testing Market Analysis, 2016-2026
      1. Market size & Analysis
        1. Market Revenue
      2. Market Share & Analysis
        1. By Type
        2. By Acquisition
        3. By Technology
        4. By Age Group
        5. By Products
    5. France Rare Disease Testing Market Analysis, 2016-2026
      1. Market size & Analysis
        1. Market Revenue
      2. Market Share & Analysis
        1. By Type
        2. By Acquisition
        3. By Technology
        4. By Age Group
        5. By Products
    6. Spain Rare Disease Testing Market Analysis, 2016-2026
      1. Market size & Analysis
        1. Market Revenue
      2. Market Share & Analysis
        1. By Type
        2. By Acquisition
        3. By Technology
        4. By Age Group
        5. By Products
    7. UK Rare Disease Testing Market Analysis, 2016-2026
      1. Market size & Analysis
        1. Market Revenue
      2. Market Share & Analysis
        1. By Type
        2. By Acquisition
        3. By Technology
        4. By Age Group
        5. By Products
  12. Middle East & Africa Rare Disease Testing Market Analysis, 2016-2026
    1. Market size & Analysis
      1. Market Revenue
    2. Market Share & Analysis
      1. By Type
      2. By Acquisition
      3. By Technology
      4. By Age Group
      5. By Products
      6. By Country
        1. Israel
        2. GCC
    3. Israel Rare Disease Testing Market Analysis, 2016-2026
      1. Market size & Analysis
        1. Market Revenue
      2. Market Share & Analysis
        1. By Type
        2. By Acquisition
        3. By Technology
        4. By Age Group
        5. By Products
    4. GCC Rare Disease Testing Market Analysis, 2016-2026
      1. Market Revenue
        1. Market Share & Analysis
        2. By Type
        3. By Acquisition
        4. By Technology
        5. By Age Group
        6. By Products
  13. Asia Pacific Rare Disease Testing Market Analysis, 2016-2026
    1. Market size & Analysis
      1. Market Revenue
    2. Market Share & Analysis
      1. By Type
      2. By Acquisition
      3. By Technology
      4. By Age Group
      5. By Products
      6. By Country
        1. China
        2. India
        3. Japan
        4. Australia
        5. Singapore
    3. China Rare Disease Testing Market Analysis, 2016-2026
      1. Market size & Analysis
        1. Market Revenue
      2. Market Share & Analysis
        1. By Type
        2. By Acquisition
        3. By Technology
        4. By Age Group
        5. By Products
        6. By Country
    4. India Rare Disease Testing Market Analysis, 2016-2026
      1. Market size & Analysis
        1. Market Revenue
      2. Market Share & Analysis
        1. By Type
        2. By Acquisition
        3. By Technology
        4. By Age Group
        5. By Products
        6. By Country
    5. Japan Rare Disease Testing Market Analysis, 2016-2026
      1. Market size & Analysis
        1. Market Revenue
      2. Market Share & Analysis
        1. By Type
        2. By Acquisition
        3. By Technology
        4. By Age Group
        5. By Products
        6. By Country
    6. Australia Rare Disease Testing Market Analysis, 2016-2026
      1. Market size & Analysis
        1. Market Revenue
      2. Market Share & Analysis
        1. By Type
        2. By Acquisition
        3. By Technology
        4. By Age Group
        5. By Products
        6. By Country
    7. Singapore Rare Disease Testing Market Analysis, 2016-2026
      1. Market size & Analysis
        1. Market Revenue
      2. Market Share & Analysis
        1. By Type
        2. By Acquisition
        3. By Technology
        4. By Age Group
        5. By Products
        6. By Country
  14. Global Rare Disease Testing for Market Growth & Competition Outlook
    1. Competition Matrix
      1. Target Market
      2. Target End User
      3. Research & Development
      4. Strategic Initiatives
    2. Company Profiles (Business Description, Product and Services Segments, Business Segments, Future Plans)
      1. Quest Diagnostics Inc.
      2. Centogene N.V.
      3. Invitae Corporation.
      4. 3billion, Inc.
      5. Arup Laboratories.
      6. Eurofins Scientific.
      7. Strand Life Sciences.
      8. Ambry Genetics.
      9. Color Genomics, Inc.
      10. Health Network Laboratories
      11. PreventionGenetics
      12. Progenity, Inc.
      13. Myriad Genetics, Inc.
      14. Laboratory Corporation of America Holdings
      15. OPKO Health, Inc.
  15. Disclaimer
Global Rare Disease Testing Market Segmentation
*This field is required